Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 271 to 280 of 335 resources

  • Shooting up Infections among people who inject drugs in the United Kingdom 2013: An update November 2014
    A Public Health England update on the 2013 report, highlighting that hepatitis C levels are still high; that hepatitis B is now rare and vaccine uptake has improved; that HIV levels remain low and the uptake of care is good; that bacterial infections remain a major problem; that injecting risk behaviours have declined but remain a problem; and that changing patterns of psychoactive drug injection are a cause for concern. The report recommends that the provision of effective interventions need to be maintained.
    England Nov 2014 Reports & Research PDF
  • Shooting Up: Infections among people who inject drugs in the UK 2011. An update: November 2012
    People who inject drugs (PWID) are vulnerable to a wide range of viral and bacterial infections. These infections can result in high levels of illness and in death, so public health surveillance of infectious diseases and the associated risk and protective behaviours among this group are important. This report describes time trends on the extent of infections among PWID in the UK to the end of 2011. This year’s report focuses on hepatitis B virus infection but also contains updates on hepatitis C, HIV and bacterial infections.
    UK Nov 2012 Reports & Research PDF
  • Shooting Up: Infections among people who inject drugs in the UK 2012: An update November 2013
    A Public Health England update on the 2012 report, looking at changing patterns of injecting drug use in England; injection of image and performance enhancing drugs; changing patterns of psychoactive drug injection; and providing an update on infections and behaviours, as well as making recommendations.
    England Nov 2013 Reports & Research PDF
  • Shooting Up: Infections among people who inject drugs in the UK 2014 - An update, November 2015
    This annual national report describes trends in the extent of infections and associated risks and behaviours among people who inject drugs in the UK to the end of 2014. Among its findings are that:

    - Two in five of those people in the UK who inject psychoactive drugs are living with hepatitis C, with around half of these infections remaining undiagnosed.
    - Changing patterns of psychoactive drug injection are increasing the risk of infection.
    UK, England, Northern Ireland, Scotland, Wales Nov 2015 Reports & Research PDF
  • Shooting Up: Infections among people who inject drugs in the UK, 2016
    This resource, produced by Public Health England, provides an annual update on infections among people who inject drugs (PWIDs) in the UK. The report reveals that hepatitis C remains the most common blood-borne infection among PWIDs, and that approximately half (48%) of hepatitis C infections among PWIDs remain undiagnosed. Of those who were unaware of their infection, 22% reported that they had never been tested, and of those unaware but tested, 44% reported that their last test had been more than two years earlier.
    UK Reports & Research PDF
  • Signposting the Way to Elimination by 2025
    The Hepatitis C Coalition is an umbrella group of leading clinicians, patient organisations, professional groups, industry and other interested parties committed to the reduction of morbidity and mortality associated with hepatitis C and its eventual elimination. This collaborative strategy builds on the release of the All-Party Parliamentary Group on Liver Health's 'Eliminating Hepatitis C in England' report and Public Health England's 'Hepatitis C in England: 2018 Report', with the aim of coordinating action by the key stakeholders involved in delivering elimination.
    England Reports & Research, Strategy & Planning PDF
  • Social Impact of HCV
    This presentation from Dr Rui Tato Marinho, Gastroenterologist at Lisbon Medical School, was first delivered at the 'HCV and Your Body' conference in Amsterdam in November 2014. It provides an overview of the physical, mental and social impact of hepatitis C, and covers issues such as stigma; homelessness; unemployment and loss of productivity.
    UK, Rest of World Nov 2014 Other, Reports & Research PDF
  • Standards for Local Surveillance and Follow Up of Hepatitis B and C
    These standards, produced by the Health Protection Agency in 2011, recognise that the detection and clinical management of hepatitis B and C can involve a number of health professionals, creating a diversity of clinical pathways. The development of the standards has also taken into account the fact that the prevalence of both hepatitis B and C varies markedly across the country and that current systems for the surveillance and follow up of cases also vary.
    UK 2011 Reports & Research, Tools & Templates, Strategy & Planning PDF
  • Steve Callaghan: HCV Action Commissioning Toolkit

    Steve Callaghan, who co-led development of the HCV Action Commissioning Toolkit, introduces the resource for commissioners of hepatitis C. The toolkit explains why effective commissioning for hepatitis C is essential, and gives advice on commissioning for outcomes under the new NHS by effectively assessing need, gathering evidence, developing services and measuring results. 

    UK Case study Video
  • Summary report: Bristol & Severn ODN workshop, Bristol
    This report provides a summary of the Bristol & Severn ODN Workshop held by HCV Action, in partnership with the ODN, in Bristol on 14th September 2017. The workshop brought together a range of stakeholders working across the hepatitis C pathway in the Bristol & Severn ODN region, with the aim of discussing some of the barriers faced by the ODN, as well as providing a forum in which to develop solutions to some of these challenges. The report includes summaries of the day's talks and group discussion, as well as suggested next steps to be taken following the event.
    South West Reports & Research PDF